Anti‐cancer stem cell activity of a hedgehog inhibitor <scp>GANT</scp>61 in estrogen receptor‐positive breast cancer cells

Junichi Kurebayashi(Kawasaki Medical School), Takuya Moriya(Kawasaki Medical School)

Cancer Science

February 17, 2017

10.1111/cas.13205

Cited by 44

Related Papers

Severe acute interstitial pneumonia and gefitinib

|The Lancet|2003|456

Preferential antitumor effect of the Src inhibitor dasatinib associated with a decreased proportion of aldehyde dehydrogenase 1-positive cells in breast cancer cells of the basal B subtype

|BMC Cancer|2010|43

Resistance to cyclin-dependent kinase (CDK) 4/6 inhibitors confers cross-resistance to other CDK inhibitors but not to chemotherapeutic agents in breast cancer cells

|Breast Cancer|2020|38